VRDN Stock-Based Compensation
Viridian Therapeutics Ors Inc · Stock-Based Compensation
VRDN Stock-Based Compensation
Latest reported$53.61Mperiod ending
VRDN Stock-Based Comp ($7.96K → $53.61M)
Annual stock-based compensation
High-resolution chart · PNG
VRDN stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 44,303,000 | |
| 42,150,000 | |
| 67,172,000 | |
| 19,765,000 | |
| 14,465,000 | |
| 3,645,000 | |
| 3,970,000 | |
| 3,679,000 | |
| 2,409,000 | |
| 2,111,000 | |
| 3,015,000 | |
| 4,298,000 | |
| 0 | |
| 7,955 |